ASTH

----

Weekly Recap | NAUT.US +103.59%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Nautilus Biotechnology (NAUT.US) rallied 103.59% this week to close at $1.96, while the S&P 500 slipped 0.27%, leaving NAUT roughly 103.86 percentage points ahead of the benchmark. The stock opened Monday at $1.00 and climbed every session, breaking to $1.365 on Tuesday and finishing the week at $1.96, a one-way move with a 97.97% intraweek amplitude.

The Week

Nautilus Biotechnology (NAUT.US) rallied 103.59% this week to close at $1.96, while the S&P 500 slipped 0.27%, leaving NAUT roughly 103.86 percentage points ahead of the benchmark. The stock opened Monday at $1.00 and climbed every session, breaking to $1.365 on Tuesday and finishing the week at $1.96, a one-way move with a 97.97% intraweek amplitude.

Key Events

The week centred on analyst actions. Roth Capital initiated coverage with a bullish view on Tuesday, when NAUT rose 8.11% in pre-market. On Wednesday Roth Capital raised its price target and NAUT jumped 18.01% intraday, with the firm lifting the stock to a strong-buy rating. Friday brought another pre-market gain of 7.01% and an 18.41% intraday move, with reports citing the price target hike and new management direction. From first coverage to the rating upgrade, company-specific news drove the tape.

Analyst Ratings

Four brokers cover the stock. Four rate it buy, none neutral, none underweight or sell. The consensus is strong-buy, with a consensus target price of $3.83, roughly 95.58% above the spot price of $1.96. Target prices range from $3.50 to $4.00, suggesting limited dispersion. NAUT ranks 37th out of 54 in its industry.

The Week Ahead

The macro calendar is busy. Monday brings the S&P Global services PMI final print and the ISM non-manufacturing PMI. Tuesday has international trade and goods trade balance data, and Wednesday sees EIA crude and Cushing inventory reports. NAUT has no earnings due, but the question is whether this week’s rating-driven momentum can hold as macro data resets the risk backdrop for small caps.

In Short

NAUT more than doubled this week, with a strong-buy consensus and a target price nearly 96% above spot, leaving a wide gap between price and target. But volume ran about 15 times its typical level, signalling rapid exchange of shares. The broker view is clearly oriented to the upside and dispersion is low. The test ahead is whether macro data and risk appetite can absorb the supply after such a sharp move.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock1,665characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.